nodes	percent_of_prediction	percent_of_DWPC	metapath
Mivacurium—BCHE—Irinotecan—pancreatic cancer	0.0928	1	CbGbCtD
Mivacurium—Hypoxemia—Gemcitabine—pancreatic cancer	0.0756	0.0962	CcSEcCtD
Mivacurium—Hypoxia—Gemcitabine—pancreatic cancer	0.0239	0.0304	CcSEcCtD
Mivacurium—Injection site reaction—Gemcitabine—pancreatic cancer	0.0151	0.0192	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Irinotecan—pancreatic cancer	0.0117	0.0149	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Gemcitabine—pancreatic cancer	0.0114	0.0145	CcSEcCtD
Mivacurium—Injection site reaction—Docetaxel—pancreatic cancer	0.0107	0.0136	CcSEcCtD
Mivacurium—Flushing—Tamoxifen—pancreatic cancer	0.0103	0.0131	CcSEcCtD
Mivacurium—Arrhythmia—Tamoxifen—pancreatic cancer	0.00991	0.0126	CcSEcCtD
Mivacurium—Mediastinal disorder—Erlotinib—pancreatic cancer	0.00989	0.0126	CcSEcCtD
Mivacurium—Arrhythmia—Erlotinib—pancreatic cancer	0.0098	0.0125	CcSEcCtD
Mivacurium—Bradycardia—Sunitinib—pancreatic cancer	0.00967	0.0123	CcSEcCtD
Mivacurium—Erythema—Tamoxifen—pancreatic cancer	0.00965	0.0123	CcSEcCtD
Mivacurium—Erythema—Erlotinib—pancreatic cancer	0.00955	0.0121	CcSEcCtD
Mivacurium—Bronchospasm—Gemcitabine—pancreatic cancer	0.00937	0.0119	CcSEcCtD
Mivacurium—Muscle spasms—Tamoxifen—pancreatic cancer	0.00928	0.0118	CcSEcCtD
Mivacurium—Phlebitis—Docetaxel—pancreatic cancer	0.00908	0.0115	CcSEcCtD
Mivacurium—Flushing—Sunitinib—pancreatic cancer	0.00882	0.0112	CcSEcCtD
Mivacurium—Cardiac disorder—Sunitinib—pancreatic cancer	0.00882	0.0112	CcSEcCtD
Mivacurium—Angiopathy—Sunitinib—pancreatic cancer	0.00862	0.011	CcSEcCtD
Mivacurium—Immune system disorder—Sunitinib—pancreatic cancer	0.00858	0.0109	CcSEcCtD
Mivacurium—Mediastinal disorder—Sunitinib—pancreatic cancer	0.00856	0.0109	CcSEcCtD
Mivacurium—Arrhythmia—Sunitinib—pancreatic cancer	0.00849	0.0108	CcSEcCtD
Mivacurium—Erythema—Sunitinib—pancreatic cancer	0.00827	0.0105	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.00808	0.0103	CcSEcCtD
Mivacurium—Bradycardia—Irinotecan—pancreatic cancer	0.00797	0.0101	CcSEcCtD
Mivacurium—Muscle spasms—Sunitinib—pancreatic cancer	0.00795	0.0101	CcSEcCtD
Mivacurium—Skin disorder—Erlotinib—pancreatic cancer	0.00757	0.00963	CcSEcCtD
Mivacurium—Cardiac disorder—Irinotecan—pancreatic cancer	0.00726	0.00924	CcSEcCtD
Mivacurium—Flushing—Irinotecan—pancreatic cancer	0.00726	0.00924	CcSEcCtD
Mivacurium—Injection site reaction—Epirubicin—pancreatic cancer	0.00722	0.00919	CcSEcCtD
Mivacurium—Angiopathy—Irinotecan—pancreatic cancer	0.0071	0.00903	CcSEcCtD
Mivacurium—Cardiac disorder—Gemcitabine—pancreatic cancer	0.00707	0.009	CcSEcCtD
Mivacurium—Immune system disorder—Irinotecan—pancreatic cancer	0.00707	0.00899	CcSEcCtD
Mivacurium—Mediastinal disorder—Irinotecan—pancreatic cancer	0.00705	0.00897	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.00699	0.00889	CcSEcCtD
Mivacurium—Arrhythmia—Irinotecan—pancreatic cancer	0.00699	0.00889	CcSEcCtD
Mivacurium—Angiopathy—Gemcitabine—pancreatic cancer	0.00691	0.0088	CcSEcCtD
Mivacurium—Immune system disorder—Gemcitabine—pancreatic cancer	0.00688	0.00876	CcSEcCtD
Mivacurium—Mediastinal disorder—Gemcitabine—pancreatic cancer	0.00687	0.00874	CcSEcCtD
Mivacurium—Arrhythmia—Gemcitabine—pancreatic cancer	0.00681	0.00866	CcSEcCtD
Mivacurium—Arrhythmia—Fluorouracil—pancreatic cancer	0.00669	0.00852	CcSEcCtD
Mivacurium—Injection site reaction—Doxorubicin—pancreatic cancer	0.00668	0.0085	CcSEcCtD
Mivacurium—Bronchospasm—Docetaxel—pancreatic cancer	0.00665	0.00845	CcSEcCtD
Mivacurium—Erythema—Gemcitabine—pancreatic cancer	0.00663	0.00844	CcSEcCtD
Mivacurium—Skin disorder—Sunitinib—pancreatic cancer	0.00655	0.00834	CcSEcCtD
Mivacurium—Muscle spasms—Irinotecan—pancreatic cancer	0.00655	0.00833	CcSEcCtD
Mivacurium—Erythema—Fluorouracil—pancreatic cancer	0.00652	0.0083	CcSEcCtD
Mivacurium—Urticaria—Tamoxifen—pancreatic cancer	0.00626	0.00796	CcSEcCtD
Mivacurium—Phlebitis—Epirubicin—pancreatic cancer	0.00612	0.00779	CcSEcCtD
Mivacurium—Phlebitis—Doxorubicin—pancreatic cancer	0.00566	0.0072	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.00561	0.00714	CcSEcCtD
Mivacurium—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00556	0.00707	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.00545	0.00693	CcSEcCtD
Mivacurium—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00541	0.00689	CcSEcCtD
Mivacurium—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00532	0.00677	CcSEcCtD
Mivacurium—Skin disorder—Gemcitabine—pancreatic cancer	0.00526	0.00669	CcSEcCtD
Mivacurium—Dizziness—Tamoxifen—pancreatic cancer	0.00521	0.00663	CcSEcCtD
Mivacurium—Tachycardia—Fluorouracil—pancreatic cancer	0.0052	0.00661	CcSEcCtD
Mivacurium—Hypotension—Irinotecan—pancreatic cancer	0.00519	0.00661	CcSEcCtD
Mivacurium—Dizziness—Erlotinib—pancreatic cancer	0.00515	0.00656	CcSEcCtD
Mivacurium—Hypotension—Gemcitabine—pancreatic cancer	0.00506	0.00644	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.00504	0.00641	CcSEcCtD
Mivacurium—Flushing—Docetaxel—pancreatic cancer	0.00502	0.00639	CcSEcCtD
Mivacurium—Cardiac disorder—Docetaxel—pancreatic cancer	0.00502	0.00639	CcSEcCtD
Mivacurium—Hypotension—Fluorouracil—pancreatic cancer	0.00497	0.00633	CcSEcCtD
Mivacurium—Rash—Tamoxifen—pancreatic cancer	0.00497	0.00632	CcSEcCtD
Mivacurium—Dermatitis—Tamoxifen—pancreatic cancer	0.00496	0.00631	CcSEcCtD
Mivacurium—Rash—Erlotinib—pancreatic cancer	0.00492	0.00625	CcSEcCtD
Mivacurium—Dermatitis—Erlotinib—pancreatic cancer	0.00491	0.00625	CcSEcCtD
Mivacurium—Angiopathy—Docetaxel—pancreatic cancer	0.00491	0.00624	CcSEcCtD
Mivacurium—Immune system disorder—Docetaxel—pancreatic cancer	0.00489	0.00621	CcSEcCtD
Mivacurium—Mediastinal disorder—Docetaxel—pancreatic cancer	0.00487	0.0062	CcSEcCtD
Mivacurium—Arrhythmia—Docetaxel—pancreatic cancer	0.00483	0.00615	CcSEcCtD
Mivacurium—Erythema—Docetaxel—pancreatic cancer	0.00471	0.00599	CcSEcCtD
Mivacurium—Muscle spasms—Docetaxel—pancreatic cancer	0.00453	0.00576	CcSEcCtD
Mivacurium—Dizziness—Sunitinib—pancreatic cancer	0.00446	0.00568	CcSEcCtD
Mivacurium—Rash—Sunitinib—pancreatic cancer	0.00425	0.00541	CcSEcCtD
Mivacurium—Dermatitis—Sunitinib—pancreatic cancer	0.00425	0.00541	CcSEcCtD
Mivacurium—Urticaria—Fluorouracil—pancreatic cancer	0.00423	0.00538	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.00398	0.00506	CcSEcCtD
Mivacurium—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00384	0.00489	CcSEcCtD
Mivacurium—Tachycardia—Docetaxel—pancreatic cancer	0.00375	0.00477	CcSEcCtD
Mivacurium—Skin disorder—Docetaxel—pancreatic cancer	0.00373	0.00475	CcSEcCtD
Mivacurium—Bradycardia—Epirubicin—pancreatic cancer	0.00371	0.00472	CcSEcCtD
Mivacurium—Dizziness—Irinotecan—pancreatic cancer	0.00368	0.00468	CcSEcCtD
Mivacurium—Hypotension—Docetaxel—pancreatic cancer	0.00359	0.00457	CcSEcCtD
Mivacurium—Dizziness—Fluorouracil—pancreatic cancer	0.00352	0.00448	CcSEcCtD
Mivacurium—Rash—Irinotecan—pancreatic cancer	0.0035	0.00446	CcSEcCtD
Mivacurium—Dermatitis—Irinotecan—pancreatic cancer	0.0035	0.00445	CcSEcCtD
Mivacurium—Bradycardia—Doxorubicin—pancreatic cancer	0.00344	0.00437	CcSEcCtD
Mivacurium—Rash—Gemcitabine—pancreatic cancer	0.00341	0.00434	CcSEcCtD
Mivacurium—Dermatitis—Gemcitabine—pancreatic cancer	0.00341	0.00434	CcSEcCtD
Mivacurium—Flushing—Epirubicin—pancreatic cancer	0.00339	0.00431	CcSEcCtD
Mivacurium—Cardiac disorder—Epirubicin—pancreatic cancer	0.00339	0.00431	CcSEcCtD
Mivacurium—Rash—Fluorouracil—pancreatic cancer	0.00336	0.00427	CcSEcCtD
Mivacurium—Dermatitis—Fluorouracil—pancreatic cancer	0.00335	0.00427	CcSEcCtD
Mivacurium—Angiopathy—Epirubicin—pancreatic cancer	0.00331	0.00421	CcSEcCtD
Mivacurium—Immune system disorder—Epirubicin—pancreatic cancer	0.0033	0.00419	CcSEcCtD
Mivacurium—Mediastinal disorder—Epirubicin—pancreatic cancer	0.00329	0.00418	CcSEcCtD
Mivacurium—Arrhythmia—Epirubicin—pancreatic cancer	0.00326	0.00415	CcSEcCtD
Mivacurium—Erythema—Epirubicin—pancreatic cancer	0.00318	0.00404	CcSEcCtD
Mivacurium—Flushing—Doxorubicin—pancreatic cancer	0.00313	0.00398	CcSEcCtD
Mivacurium—Cardiac disorder—Doxorubicin—pancreatic cancer	0.00313	0.00398	CcSEcCtD
Mivacurium—Angiopathy—Doxorubicin—pancreatic cancer	0.00306	0.0039	CcSEcCtD
Mivacurium—Muscle spasms—Epirubicin—pancreatic cancer	0.00305	0.00388	CcSEcCtD
Mivacurium—Immune system disorder—Doxorubicin—pancreatic cancer	0.00305	0.00388	CcSEcCtD
Mivacurium—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.00304	0.00387	CcSEcCtD
Mivacurium—Arrhythmia—Doxorubicin—pancreatic cancer	0.00302	0.00384	CcSEcCtD
Mivacurium—Erythema—Doxorubicin—pancreatic cancer	0.00294	0.00374	CcSEcCtD
Mivacurium—Muscle spasms—Doxorubicin—pancreatic cancer	0.00283	0.00359	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.00269	0.00342	CcSEcCtD
Mivacurium—Anaphylactic shock—Epirubicin—pancreatic cancer	0.00259	0.0033	CcSEcCtD
Mivacurium—Dizziness—Docetaxel—pancreatic cancer	0.00254	0.00323	CcSEcCtD
Mivacurium—Tachycardia—Epirubicin—pancreatic cancer	0.00253	0.00322	CcSEcCtD
Mivacurium—Skin disorder—Epirubicin—pancreatic cancer	0.00252	0.0032	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.00248	0.00316	CcSEcCtD
Mivacurium—Rash—Docetaxel—pancreatic cancer	0.00242	0.00308	CcSEcCtD
Mivacurium—Hypotension—Epirubicin—pancreatic cancer	0.00242	0.00308	CcSEcCtD
Mivacurium—Dermatitis—Docetaxel—pancreatic cancer	0.00242	0.00308	CcSEcCtD
Mivacurium—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.0024	0.00305	CcSEcCtD
Mivacurium—Tachycardia—Doxorubicin—pancreatic cancer	0.00234	0.00298	CcSEcCtD
Mivacurium—Skin disorder—Doxorubicin—pancreatic cancer	0.00233	0.00296	CcSEcCtD
Mivacurium—Hypotension—Doxorubicin—pancreatic cancer	0.00224	0.00285	CcSEcCtD
Mivacurium—Urticaria—Epirubicin—pancreatic cancer	0.00206	0.00262	CcSEcCtD
Mivacurium—Urticaria—Doxorubicin—pancreatic cancer	0.00191	0.00242	CcSEcCtD
Mivacurium—Dizziness—Epirubicin—pancreatic cancer	0.00171	0.00218	CcSEcCtD
Mivacurium—Rash—Epirubicin—pancreatic cancer	0.00163	0.00208	CcSEcCtD
Mivacurium—Dermatitis—Epirubicin—pancreatic cancer	0.00163	0.00208	CcSEcCtD
Mivacurium—Dizziness—Doxorubicin—pancreatic cancer	0.00159	0.00202	CcSEcCtD
Mivacurium—Rash—Doxorubicin—pancreatic cancer	0.00151	0.00192	CcSEcCtD
Mivacurium—Dermatitis—Doxorubicin—pancreatic cancer	0.00151	0.00192	CcSEcCtD
Mivacurium—CHRM3—Signaling Pathways—ACVR1B—pancreatic cancer	0.000141	0.00117	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—ZNRF3—pancreatic cancer	0.000141	0.00117	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—IAPP—pancreatic cancer	0.000141	0.00117	CbGpPWpGaD
Mivacurium—CHRM2—G alpha (i) signalling events—CXCL8—pancreatic cancer	0.000141	0.00117	CbGpPWpGaD
Mivacurium—CHRM2—Regulation of Actin Cytoskeleton—KRAS—pancreatic cancer	0.00014	0.00116	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—ACVR1B—pancreatic cancer	0.00014	0.00116	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—ZNRF3—pancreatic cancer	0.00014	0.00116	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	0.000137	0.00114	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000137	0.00113	CbGpPWpGaD
Mivacurium—CHRM2—SIDS Susceptibility Pathways—TNF—pancreatic cancer	0.000136	0.00113	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000135	0.00112	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—GLP1R—pancreatic cancer	0.000134	0.00111	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—DPYD—pancreatic cancer	0.000132	0.00109	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—SHH—pancreatic cancer	0.000131	0.00108	CbGpPWpGaD
Mivacurium—CHRM3—Regulation of Actin Cytoskeleton—PIK3CA—pancreatic cancer	0.00013	0.00108	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—SHH—pancreatic cancer	0.00013	0.00107	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—IAPP—pancreatic cancer	0.000129	0.00107	CbGpPWpGaD
Mivacurium—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—pancreatic cancer	0.000129	0.00106	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—IAPP—pancreatic cancer	0.000128	0.00106	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—TYMP—pancreatic cancer	0.000128	0.00106	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—DTX1—pancreatic cancer	0.000128	0.00106	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—SSTR3—pancreatic cancer	0.000128	0.00106	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—SSTR3—pancreatic cancer	0.000127	0.00105	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—DTX1—pancreatic cancer	0.000127	0.00105	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—SLC2A2—pancreatic cancer	0.000125	0.00104	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—SST—pancreatic cancer	0.000125	0.00103	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—PTCH1—pancreatic cancer	0.000124	0.00103	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—PTHLH—pancreatic cancer	0.000124	0.00103	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	0.000124	0.00102	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—SST—pancreatic cancer	0.000124	0.00102	CbGpPWpGaD
Mivacurium—BCHE—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.000124	0.00102	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—PTHLH—pancreatic cancer	0.000123	0.00102	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—PTCH1—pancreatic cancer	0.000123	0.00102	CbGpPWpGaD
Mivacurium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatic cancer	0.000123	0.00101	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—SSTR1—pancreatic cancer	0.000123	0.00101	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—SSTR1—pancreatic cancer	0.000121	0.001	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PPY—pancreatic cancer	0.00012	0.000993	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	0.00012	0.000989	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PPY—pancreatic cancer	0.000119	0.000983	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—SSTR2—pancreatic cancer	0.000118	0.000974	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—SSTR2—pancreatic cancer	0.000117	0.000965	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—CNR1—pancreatic cancer	0.000115	0.000954	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—CNR1—pancreatic cancer	0.000114	0.000945	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CCKBR—pancreatic cancer	0.000114	0.000941	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—SST—pancreatic cancer	0.000114	0.000939	CbGpPWpGaD
Mivacurium—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000113	0.000936	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CCKBR—pancreatic cancer	0.000113	0.000932	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—SST—pancreatic cancer	0.000113	0.00093	CbGpPWpGaD
Mivacurium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000112	0.000927	CbGpPWpGaD
Mivacurium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	0.000112	0.000924	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—GCG—pancreatic cancer	0.000112	0.000921	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—GCG—pancreatic cancer	0.00011	0.000912	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	0.000109	0.000901	CbGpPWpGaD
Mivacurium—CHRM3—G alpha (q) signalling events—PIK3CA—pancreatic cancer	0.000109	0.000896	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—GLI1—pancreatic cancer	0.000107	0.000885	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—DTX4—pancreatic cancer	0.000107	0.000885	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000106	0.000879	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—GLI1—pancreatic cancer	0.000106	0.000876	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—DTX4—pancreatic cancer	0.000106	0.000876	CbGpPWpGaD
Mivacurium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	0.000106	0.000873	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000105	0.00087	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—CNR1—pancreatic cancer	0.000105	0.000866	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000104	0.000861	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NRP1—pancreatic cancer	0.000104	0.000861	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—CNR1—pancreatic cancer	0.000104	0.000858	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—GLP1R—pancreatic cancer	0.000103	0.000853	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000103	0.000852	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NRP1—pancreatic cancer	0.000103	0.000852	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—DPYD—pancreatic cancer	0.000102	0.000839	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—GCG—pancreatic cancer	0.000101	0.000837	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—GCG—pancreatic cancer	0.0001	0.000829	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—HEY2—pancreatic cancer	0.0001	0.000828	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—HEY2—pancreatic cancer	9.93e-05	0.00082	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—GAST—pancreatic cancer	9.79e-05	0.000809	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—CD44—pancreatic cancer	9.71e-05	0.000802	CbGpPWpGaD
Mivacurium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	9.71e-05	0.000802	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—GAST—pancreatic cancer	9.7e-05	0.000801	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—AGTR1—pancreatic cancer	9.66e-05	0.000798	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—SLC2A2—pancreatic cancer	9.64e-05	0.000796	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—AGTR1—pancreatic cancer	9.57e-05	0.00079	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	9.5e-05	0.000785	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—MMP2—pancreatic cancer	9.5e-05	0.000785	CbGpPWpGaD
Mivacurium—BCHE—Neuronal System—HRAS—pancreatic cancer	9.48e-05	0.000783	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	9.42e-05	0.000778	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—GCG—pancreatic cancer	9.31e-05	0.000769	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—SCT—pancreatic cancer	9.29e-05	0.000767	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—HEY1—pancreatic cancer	9.29e-05	0.000767	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—HEY1—pancreatic cancer	9.2e-05	0.00076	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—SCT—pancreatic cancer	9.2e-05	0.00076	CbGpPWpGaD
Mivacurium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	8.98e-05	0.000742	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CCK—pancreatic cancer	8.86e-05	0.000732	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CCK—pancreatic cancer	8.77e-05	0.000725	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—STK11—pancreatic cancer	8.75e-05	0.000723	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CNR2—pancreatic cancer	8.63e-05	0.000713	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—GLP1R—pancreatic cancer	8.63e-05	0.000713	CbGpPWpGaD
Mivacurium—CHRM3—GPCR ligand binding—CXCL8—pancreatic cancer	8.63e-05	0.000713	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—GLP1R—pancreatic cancer	8.55e-05	0.000706	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CNR2—pancreatic cancer	8.55e-05	0.000706	CbGpPWpGaD
Mivacurium—CHRM2—GPCR ligand binding—CXCL8—pancreatic cancer	8.54e-05	0.000706	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CCKAR—pancreatic cancer	8.49e-05	0.000702	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CCKAR—pancreatic cancer	8.41e-05	0.000695	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—JAG2—pancreatic cancer	8.23e-05	0.00068	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	8.21e-05	0.000678	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—JAG2—pancreatic cancer	8.15e-05	0.000674	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MEN1—pancreatic cancer	8.12e-05	0.00067	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MEN1—pancreatic cancer	8.04e-05	0.000664	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—CXCL8—pancreatic cancer	7.89e-05	0.000652	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—SHH—pancreatic cancer	7.74e-05	0.00064	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NOTCH4—pancreatic cancer	7.69e-05	0.000636	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—SHH—pancreatic cancer	7.67e-05	0.000633	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—IAPP—pancreatic cancer	7.65e-05	0.000632	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NOTCH4—pancreatic cancer	7.62e-05	0.000629	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—IAPP—pancreatic cancer	7.57e-05	0.000626	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—TYMS—pancreatic cancer	7.53e-05	0.000622	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—CD44—pancreatic cancer	7.46e-05	0.000617	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PTCH1—pancreatic cancer	7.34e-05	0.000606	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PTHLH—pancreatic cancer	7.34e-05	0.000606	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—CTNNB1—pancreatic cancer	7.28e-05	0.000601	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PTHLH—pancreatic cancer	7.27e-05	0.0006	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PTCH1—pancreatic cancer	7.27e-05	0.0006	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—GCG—pancreatic cancer	7.16e-05	0.000591	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—STK11—pancreatic cancer	6.73e-05	0.000556	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—SST—pancreatic cancer	6.71e-05	0.000555	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—SST—pancreatic cancer	6.65e-05	0.000549	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—PIK3CG—pancreatic cancer	6.62e-05	0.000547	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—JAG1—pancreatic cancer	6.57e-05	0.000543	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—PIK3CG—pancreatic cancer	6.56e-05	0.000542	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NOTCH3—pancreatic cancer	6.54e-05	0.00054	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—JAG1—pancreatic cancer	6.51e-05	0.000537	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NOTCH3—pancreatic cancer	6.48e-05	0.000535	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CNR1—pancreatic cancer	6.2e-05	0.000512	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CNR1—pancreatic cancer	6.14e-05	0.000507	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—APOE—pancreatic cancer	6.12e-05	0.000506	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—PIK3CG—pancreatic cancer	6.01e-05	0.000497	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—GCG—pancreatic cancer	5.98e-05	0.000494	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—PIK3CG—pancreatic cancer	5.95e-05	0.000492	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—GCG—pancreatic cancer	5.93e-05	0.000489	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—PIK3CD—pancreatic cancer	5.82e-05	0.000481	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.79e-05	0.000479	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—TYMS—pancreatic cancer	5.79e-05	0.000478	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—PIK3CD—pancreatic cancer	5.76e-05	0.000476	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—AGTR1—pancreatic cancer	5.71e-05	0.000472	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—AGTR1—pancreatic cancer	5.65e-05	0.000467	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—STK11—pancreatic cancer	5.63e-05	0.000465	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—STK11—pancreatic cancer	5.57e-05	0.00046	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PIK3CG—pancreatic cancer	5.52e-05	0.000456	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PPARG—pancreatic cancer	5.33e-05	0.00044	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—PIK3CD—pancreatic cancer	5.29e-05	0.000437	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—PIK3CD—pancreatic cancer	5.23e-05	0.000432	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—PIK3CB—pancreatic cancer	5.07e-05	0.000419	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—PIK3CB—pancreatic cancer	5.02e-05	0.000415	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—SMAD4—pancreatic cancer	4.93e-05	0.000407	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—SMAD4—pancreatic cancer	4.88e-05	0.000403	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—CXCL8—pancreatic cancer	4.88e-05	0.000403	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PIK3CD—pancreatic cancer	4.86e-05	0.000401	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—CXCL8—pancreatic cancer	4.83e-05	0.000399	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—HES1—pancreatic cancer	4.81e-05	0.000397	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—HES1—pancreatic cancer	4.76e-05	0.000394	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—APOE—pancreatic cancer	4.71e-05	0.000389	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—PIK3CB—pancreatic cancer	4.61e-05	0.000381	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—PIK3CB—pancreatic cancer	4.56e-05	0.000377	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—CXCL8—pancreatic cancer	4.43e-05	0.000366	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—CXCL8—pancreatic cancer	4.38e-05	0.000362	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PIK3CG—pancreatic cancer	4.25e-05	0.000351	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PIK3CB—pancreatic cancer	4.23e-05	0.00035	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—TERT—pancreatic cancer	4.22e-05	0.000348	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PTGS2—pancreatic cancer	4.19e-05	0.000346	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—TERT—pancreatic cancer	4.17e-05	0.000345	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PPARG—pancreatic cancer	4.1e-05	0.000339	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—HIF1A—pancreatic cancer	4.03e-05	0.000333	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—TSC2—pancreatic cancer	4.02e-05	0.000332	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—HIF1A—pancreatic cancer	3.99e-05	0.00033	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—TSC2—pancreatic cancer	3.98e-05	0.000329	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—APOE—pancreatic cancer	3.94e-05	0.000325	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—APOE—pancreatic cancer	3.9e-05	0.000322	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—KDR—pancreatic cancer	3.86e-05	0.000319	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—KDR—pancreatic cancer	3.82e-05	0.000315	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PIK3CD—pancreatic cancer	3.73e-05	0.000308	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NFKBIA—pancreatic cancer	3.67e-05	0.000303	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PTEN—pancreatic cancer	3.66e-05	0.000302	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NOTCH1—pancreatic cancer	3.63e-05	0.0003	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NFKBIA—pancreatic cancer	3.63e-05	0.0003	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NOTCH1—pancreatic cancer	3.6e-05	0.000297	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PIK3CG—pancreatic cancer	3.55e-05	0.000293	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—NRAS—pancreatic cancer	3.55e-05	0.000293	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PIK3CG—pancreatic cancer	3.52e-05	0.000291	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—NRAS—pancreatic cancer	3.52e-05	0.000291	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—EGF—pancreatic cancer	3.51e-05	0.00029	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—EGF—pancreatic cancer	3.48e-05	0.000287	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PIK3CB—pancreatic cancer	3.25e-05	0.000269	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—EGFR—pancreatic cancer	3.24e-05	0.000267	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PTGS2—pancreatic cancer	3.22e-05	0.000266	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—EGFR—pancreatic cancer	3.2e-05	0.000265	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PIK3CD—pancreatic cancer	3.12e-05	0.000258	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.09e-05	0.000255	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PIK3CD—pancreatic cancer	3.09e-05	0.000255	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.06e-05	0.000253	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—KRAS—pancreatic cancer	3.06e-05	0.000253	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—KRAS—pancreatic cancer	3.03e-05	0.00025	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PTEN—pancreatic cancer	2.81e-05	0.000232	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—PIK3CA—pancreatic cancer	2.81e-05	0.000232	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—PIK3CA—pancreatic cancer	2.78e-05	0.00023	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PIK3CB—pancreatic cancer	2.72e-05	0.000225	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PIK3CB—pancreatic cancer	2.7e-05	0.000223	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CXCL8—pancreatic cancer	2.62e-05	0.000216	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—HRAS—pancreatic cancer	2.6e-05	0.000215	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CXCL8—pancreatic cancer	2.59e-05	0.000214	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PIK3CA—pancreatic cancer	2.58e-05	0.000213	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—HRAS—pancreatic cancer	2.57e-05	0.000213	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—AKT1—pancreatic cancer	2.53e-05	0.000209	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CASP3—pancreatic cancer	2.5e-05	0.000207	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—AKT1—pancreatic cancer	2.5e-05	0.000207	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CASP3—pancreatic cancer	2.48e-05	0.000205	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CCND1—pancreatic cancer	2.44e-05	0.000201	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CTNNB1—pancreatic cancer	2.41e-05	0.000199	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	2.41e-05	0.000199	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	2.39e-05	0.000197	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MMP9—pancreatic cancer	2.37e-05	0.000195	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PTEN—pancreatic cancer	2.35e-05	0.000194	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	2.34e-05	0.000194	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	2.33e-05	0.000192	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—AKT1—pancreatic cancer	2.29e-05	0.00019	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	2.27e-05	0.000188	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—SRC—pancreatic cancer	2.18e-05	0.00018	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—SRC—pancreatic cancer	2.16e-05	0.000178	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—VEGFA—pancreatic cancer	2.12e-05	0.000175	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—AKT1—pancreatic cancer	2.11e-05	0.000174	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	2.1e-05	0.000174	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—STAT3—pancreatic cancer	2.1e-05	0.000174	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NRAS—pancreatic cancer	2.1e-05	0.000173	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	2.08e-05	0.000172	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	2.08e-05	0.000172	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PIK3CA—pancreatic cancer	1.98e-05	0.000164	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MYC—pancreatic cancer	1.95e-05	0.000161	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—TGFB1—pancreatic cancer	1.95e-05	0.000161	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MYC—pancreatic cancer	1.94e-05	0.00016	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	1.93e-05	0.000159	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—EGFR—pancreatic cancer	1.91e-05	0.000158	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	1.89e-05	0.000156	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—KRAS—pancreatic cancer	1.81e-05	0.000149	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	1.79e-05	0.000148	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PIK3CA—pancreatic cancer	1.66e-05	0.000137	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	1.64e-05	0.000136	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—AKT1—pancreatic cancer	1.62e-05	0.000134	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—TP53—pancreatic cancer	1.6e-05	0.000133	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—TP53—pancreatic cancer	1.59e-05	0.000131	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—HRAS—pancreatic cancer	1.53e-05	0.000127	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	1.52e-05	0.000126	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—AKT1—pancreatic cancer	1.36e-05	0.000112	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	1.34e-05	0.000111	CbGpPWpGaD
